Serum Level of Tumor Marker In Breast Cancer Women In Different Age Groups

DOI:

https://doi.org/10.36371/port.2023.1.1

Authors

  • N. A. Ibrahim University of Baghdad, Department of Basic Sciences, College of Nursing, Baghdad, Iraq.
  • W J. Mohammad University of Baghdad, Department of Basic Sciences, College of Nursing, Baghdad, Iraq.
  • Shahad F. Obeid University of Baghdad, Department of Chemistry , College of Sciences, Baghdad, Iraq.

Breast cancer is the most common crucial cancer in women worldwide. The tumor marker Carcinoma Antigen 15-3 is frequently used for screening and monitoring breast cancer. Carcinoma antigen 15–3 (CA15-3) is used to monitor the prognosis for patients after treatment. This study aims to estimate the level of serum tumor marker CA15-3 in different age groups. Participants women diagnosed with breast cancer living in Iraq were admitted to the Middle East lab (private lab), Al-Harthia city. The study involves 176 females aged from 30 to 80 years. Data was collected from the period between March to November 2021. An automated electrochemistry luminescence immunoassay system (ROCHE E170, Germany) measured serum CA15-3 levels. When the CA15-3 marker level was above or below the cut-off value of 25 U/mL, the marker was counted positive or negative. The current study reveals that CA15-3 in the age group between (33-39) was the highest in 39 years (27.7 U/ml). Furthermore, 47 years exhibited the highest level of CA15-3 (150 U/ml) among (40-49 years) category. Meanwhile, 55 years participants showed the highest level of CA15-3 (101 U/ml) in (50-59 years) age group. 66 years old, on the other hand, showed an elevated level of CA15-3 (72 U/ml) compared to other participants in the (60-69) age group.

Keywords:

Cancer antigen, tumor marker, .Mucin1 (MUC-1) gene, , carcinoembryonic antigen (CEA), Brest cancer

[1] Stewart BW, Wild CP. World Cancer Report 2014. Geneva, Switzerland: WHO Press; 2014.

[2] Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30.

[3] DeSantis CE, Fedewa SA, Goding Sauer A. et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66:31–42.

[4] Duffy MJ, McDermott EW, Crown J. Blood-based biomarkers in breast cancer: from proteins to circulating tumor cells to circulating tumor DNA. Tumour Biol. 2018;40(5):101042831877616

[5] Hahn EE, Hays RD, Kahn KL, Litwin MS, Ganz PA. Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer. 2013;119(24):4316–4324..

[6] Stieber P, Nagel D, Blankenburg I, et al. Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer – a retrospective analysis of kinetics on 743 breast cancer patients. Clin Chim Acta. 2015;448:228–231.

[7] Molina R, Barak V, van Dalen A, Duffy MJ, Einarsson R, Gion M et al. Tumor markers in breast cancer- European Group on Tumor Markers recommendations. Tumour Biol 2005; 26:281–293 .

[8] Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007; 25:5287–5312.

[9] Wu SG, He ZY, Zhou J, Sun JY, Li FY, Lin Q et al. Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer. Breast 2014; 23:88–93. 10.1016/j.breast.2013.11.003 .

[10] Park BW, Oh JW, Kim JH, Park SH, Kim KS, Lee KS. Preoperative CA 15–3 and CEA serum levels as predictor for breast cancer outcomes. Ann Oncol 2008; 19:675–681.

[11] Lee JS, Park S, Park JM, Cho JH, Kim SI, Park BW. Elevated levels of serum tumor markers CA 15–3 and CEA are prognostic factors for diagnosis of metastatic breast cancers. Breast Cancer Res Treat 2013; 141:477–484. 10.1007/s10549-013-2695-7.

[12] Shao Y., Sun X., He Y., Liu C., Liu H. Elevated levels of serum tumor markers CEA and CA153 are prognostic parameters for different molecular subtypes of breast cancer. 2015;10(7, article e0133830) doi: 10.1371/journal.pone.0133830.

Ibrahim, N. A. ., Mohammad, W. J. ., & Obeid, S. F. (2023). Serum Level of Tumor Marker In Breast Cancer Women In Different Age Groups. Journal Port Science Research, 6(1), 1–3. https://doi.org/10.36371/port.2023.1.1

License

Copyright (c) 2023 Journal Port Science Research

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Downloads

Download data is not yet available.